Drug-Induced Parkinsonism.
Garg K, Rajan R, Singh M.
Neurol India. 2021 Mar-Apr;69(2):437-438. doi: 10.4103/0028-3886.314567.
Drug-induced parkinsonism.
Friedman JH.
Mov Disord. 2017 Jul;32(7):1111. doi: 10.1002/mds.27050. Epub 2017 Jun 14.
The diagnosis of Parkinson's disease.
Tolosa E, Wenning G, Poewe W.
Lancet Neurol. 2006 Jan;5(1):75-86. doi: 10.1016/S1474-4422(05)70285-4.
Secondary parkinsonism.
Terashi H, Taguchi T, Aizawa H.
Nihon Rinsho. 2017 Jan;75(1):63-70.
[Drug-induced parkinsonism].
Ory-Magne F.
Rev Prat. 2020 May;70(5):475-478.
Valbenazine-induced parkinsonism.
Akbar U, Kim DS, Friedman JH.
Parkinsonism Relat Disord. 2020 Jan;70:13-14. doi: 10.1016/j.parkreldis.2019.11.021. Epub 2019 Nov 25.
Drug-induced parkinsonism.
Mena MA, de Yébenes JG.
Expert Opin Drug Saf. 2006 Nov;5(6):759-71. doi: 10.1517/14740338.5.6.759.
Drug-induced parkinsonism: a review.
Montastruc JL, Llau ME, Rascol O, Senard JM.
Fundam Clin Pharmacol. 1994;8(4):293-306. doi: 10.1111/j.1472-8206.1994.tb00808.x.
Drug-induced movement disorders.
Jiménez-Jiménez FJ, García-Ruiz PJ, Molina JA.
Drug Saf. 1997 Mar;16(3):180-204. doi: 10.2165/00002018-199716030-00004.
Drug-induced experimental Parkinsonism.
Morrison AB, Webster RA.
Neuropharmacology. 1973 Aug;12(8):715-24. doi: 10.1016/0028-3908(73)90011-7.
